Does MOBOCERTINIB Cause Therapy partial responder? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Therapy partial responder have been filed in association with MOBOCERTINIB. This represents 2.4% of all adverse event reports for MOBOCERTINIB.
17
Reports of Therapy partial responder with MOBOCERTINIB
2.4%
of all MOBOCERTINIB reports
6
Deaths
2
Hospitalizations
How Dangerous Is Therapy partial responder From MOBOCERTINIB?
Of the 17 reports, 6 (35.3%) resulted in death, 2 (11.8%) required hospitalization.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOBOCERTINIB. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does MOBOCERTINIB Cause?
Diarrhoea (309)
Death (160)
Rash (106)
Non-small cell lung cancer (96)
Nausea (85)
Decreased appetite (80)
Lung neoplasm malignant (74)
Vomiting (74)
Fatigue (66)
Asthenia (56)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which MOBOCERTINIB Alternatives Have Lower Therapy partial responder Risk?
MOBOCERTINIB vs MOCLOBEMIDE
MOBOCERTINIB vs MODAFINIL
MOBOCERTINIB vs MOGAMULIZUMAB
MOBOCERTINIB vs MOGAMULIZUMAB-KPKC
MOBOCERTINIB vs MOLNUPIRAVIR